Literature DB >> 32632637

Optical coherence tomography in adult adrenoleukodystrophy: a cross-sectional and longitudinal study.

Stefania Bianchi-Marzoli1, Silvia Fenu2, Lisa Melzi1, Chiara Benzoni2, Filippo Antonazzo3, Eugenia Tomas Roldan4, Laura Farina5,6, Gemma Tremolada1, Elena Mauro2, Viviana Pensato7, Cinzia Gellera7, Davide Pareyson2, Ettore Salsano8,9.   

Abstract

BACKGROUND: Adrenoleukodystrophy (ALD) encompasses different neurological phenotypes, ranging from the most severe cerebral forms (C-ALD) to the less severe adrenomyeloneuropathy (AMN). As visual system can be varyingly involved, we aimed at exploring whether optical coherence tomography (OCT) may detect retinal abnormalities and their longitudinal changes in adult ALD patients.
METHODS: In this cross-sectional and longitudinal study, we measured the thicknesses of peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell complex (mGCC), and segmented inner and outer macula at baseline and their changes over time in 11 symptomatic adult ALD males and 10 age- and sex-matched healthy controls. Statistical analyses were performed for the patients as complete group, and splitting them into two subgroups, one (C-ALD) with and the other (AMN) without cerebral parieto-occipital white matter (WM) lesions.
RESULTS: In the complete ALD group and in the C-ALD subgroup, the average pRNFL, mGCC, and inner macula were significantly thinner than in controls (p ≤ 0.01), whereas in the AMN subgroup, they were constantly, though non-significantly, thinner. Significant outer macula thinning was also observed (p < 0.01). In the complete ALD group, follow-up assessment (mean 26.8 months, range 8-48) showed mildly progressive thinning of inferior pRNFL, average mGCC, and inner macula.
CONCLUSIONS: In adult ALD patients, OCT can reveal retinal abnormalities which are prominent in the more compromised patients, namely those with parieto-occipital WM lesions. The inferior pRNFL, average mGCC and inner macula thicknesses might be sensitive-to-change OCT parameters, but their utility and consistency for short-term longitudinal studies deserve further investigations.

Entities:  

Keywords:  Adrenoleukodystrophy; Adrenomyeloneuropathy; Leukodystrophy; Optical coherence tomography; Surrogate endpoints

Mesh:

Year:  2020        PMID: 32632637     DOI: 10.1007/s10072-020-04576-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  3 in total

1.  Adrenoleukodystrophy: a scoring method for brain MR observations.

Authors:  D J Loes; S Hite; H Moser; A E Stillman; E Shapiro; L Lockman; R E Latchaw; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

2.  Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex).

Authors:  J M Powers
Journal:  Clin Neuropathol       Date:  1985 Sep-Oct       Impact factor: 1.368

3.  Optical coherence tomography shows neuroretinal thinning in myelopathy of adrenoleukodystrophy.

Authors:  Wouter J C van Ballegoij; Sander C Kuijpers; Irene C Huffnagel; Henry C Weinstein; Bwee Tien Poll-The; Marc Engelen; Carlien A M Bennebroek; Frank D Verbraak
Journal:  J Neurol       Date:  2019-11-12       Impact factor: 4.849

  3 in total
  1 in total

1.  Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy.

Authors:  Wouter J C van Ballegoij; Irene C Huffnagel; Stephanie I W van de Stadt; Henry C Weinstein; Carlien A M Bennebroek; Marc Engelen; Frank D Verbraak
Journal:  Ann Clin Transl Neurol       Date:  2021-03-30       Impact factor: 4.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.